Expands presence in Prayagraj, bringing reliable, accurate, and affordable diagnostic services across the region Prayagraj, Uttar Pradesh, 10th June 2026: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company in India to have achieved 100% NABL accreditation across
Based on comprehensive Fever Package testing data (2023–2025), close to one-third of patients were diagnosed with dengue, typhoid and other serious infections Mumbai, 27th March 2026: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has released new
Thyrocare, one of India's leading healthcare service providers in the diagnostic segment, is all set for expansion once again. With 4 Regional Processing Labs operational in the current quarter, in Nagpur, Ranchi, Raipur and Ahmedabad, Thyrocare is all set to launch 2 Regional Processing Labs
